Results 111 to 120 of about 1,574 (155)

One God, No State, and Many Legal Arguments: Multivalent Logic in Jewish Law [PDF]

Chaim N. Saiman
core   +1 more source

Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy. [PDF]

Front Immunol
Arshad F, Chinnappan R, Mir TA, Ahmed Z, Arora I, Khan MI, Yaqinuddin A.   +6 more
europepmc   +1 more source

Advancements in DNA-Driven Precision Modulation of Cell Surface Receptor for Programmable Cellular Functions. [PDF]

Adv Sci (Weinh)
Nan H, Cai M, Wang Y, Wang HH, Nie Z.
europepmc   +1 more source

Precision nanomedicine for lung metastatic osteosarcoma: challenges, therapeutic strategies, and perspectives. [PDF]

Mater Today Bio
Li H, Luo J, Wang Q, Zhang Y, Li Q, Wang X, Liu G, Shi C, Zhang W.   +8 more
europepmc   +1 more source

Programmable molecular microscopy: CRISPR/Cas fluorescent probes revolutionizing spatiotemporal genomic imaging. [PDF]

Theranostics
Zhong XY, Yang YX, Xiong YF, Ye GC, Gong X, Zhong ML, He HD, Wang SG, Xia QD.   +8 more
europepmc   +1 more source

Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunities. [PDF]

Drug Deliv
Mao H, Zhang Y, Liu M, Yao Y, Peng Y, Zhou X, Huang H, Fei W, Zheng C, Ye Y.   +9 more
europepmc   +1 more source

Aptamer-Functionalized Nanocarriers for Bone and Joint Diseases: Engineering Design Rules and Translational Roadmap. [PDF]

Small Sci
Al-Azzani H, Vithran DTA, Batool SS, Alshabi MMA, Zhou W, Mao X.   +5 more
europepmc   +1 more source

Advancing immunotherapy via multiple immune cells co-engagement. [PDF]

Front Immunol
Li H, Zhang Y, Wei Q, Sun Q, Lin F, Chen PR.   +5 more
europepmc   +1 more source

Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures. [PDF]

Hum Vaccin Immunother
Chen S, Chen Y, Zhang Y, Yao G, Cai H, Chen X, Hu Y.   +6 more
europepmc   +1 more source